Purchase Order 75N95023P00117
Award Date 2/17/23
Potential Completion Date 3/25/23
Potential Value $84K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $127,908.40 firm fixed-price purchase order awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The award is for Promega's proprietary reagent kits and assay products, which are sole source procured due to their specialized capabilities required to support NCATS' ongoing laboratory research and high-throughput screening programs. This award was not...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company. The $83,800 contract is for the procurement of Promega reagents and assays to support NCATS' Antiviral Program for Pandemics. The award does not utilize a set-aside designation. The original solicitation states that NCATS' screening assays have been optimized using Promega...
- This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Promega Corporation for a methyltransferase assay kit, consisting of 2,000 assays. The $45,504.00 contract is to support NCATS' mission of catalyzing innovative methods and technologies for developing diagnostics and therapeutics. The assay kits will be used in NCATS' methyltransferase project to identify...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The $86,800.00 contract is for Promega Corporation, a global life sciences company, to provide reagent kits and assays. The award is not set aside for any small business designations. Promega holds several significant federal contract vehicles, including Blanket Purchase Agreements with the Defense Health...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation for $132,961.50. The order is for Promega's cytochrome P450 screening assay systems to support the Tox21 drug screening program. The assay kits measure the activity of various CYP enzymes, which are critical for evaluating drug metabolism and toxicity. This award was sole-sourced to Promega as the sole...
- The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a Firm Fixed Price Purchase Order contract to Promega Corporation, a for-profit manufacturer of biological research and diagnostic products. The $66,970.35 contract is for the delivery of Promega's proprietary laboratory equipment, reagents, and consumables to support the agency's biomedical research and testing programs. This award is under a $10 million...
- Promega Corporation received a contract award valued at $21,260 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, on April 12, 2016. This firm fixed-price BPA (Blanket Purchase Agreement) call was issued without small business set-aside designation and required performance in Madison, Wisconsin, with completion by February 28, 2017. The contract procures specialized kinase assay products including ADP-Glo Kinase Assay kits...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...
- Promega Corporation was awarded a $24,966.20 firm fixed price contract by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health, for the supply of HDAC-GLO I/II Assay reagent kits (100 mL) to support research conducted by NIH/NCATS staff members Menghang Xia and Sri Sakamuru. The award was issued on February 18, 2016, with an ultimate completion date of February 29, 2016, and was executed as a call against Promega's existing Blanket...